Departamento académico: (FM) Patología, Anatomía y Fisiología

Centro académico: Facultad de Medicina (FM)

Centro / Instituto vinculado a la Universidad de Navarra: Centro de Investigación de Medicina Aplicada (CIMA)

Organización: Universidad de Navarra

Research group: Enfermedad de Alzheimer y otras demencias

Research group: Terapia Génica en Enfermedades Neurológicas


Doctor by the Universidad de Navarra with the thesis Expresión génica diferencial y regulación de ferritina en un modelo animal de enfermedad de Parkinson 2003. Supervised by Dr. Lourdes Ortiz Hernández.

Dra. Mar Cuadrado-Tejedor received her Bachelor degree of Pharmacy at the University of País Vasco (1999) and her Doctor of Pharmacy degree from the University of Navarra (2003). She completed her doctoral thesis focused on molecular basis of Parkinson's disease. After a research stay at the Pharmacology Department at Merck Sharp & Dohme (UK), she joined Teresa Gómez Isla's lab in the Department of Neurology at the University of Navarra for her postdoctoral training in Alzheimer's disease (EA). In 2005, she joined the University of Navarra as assistant professor in the Department of Anatomy, collaborating at the same time as a researcher at the Neuroscience Program at CIMA. She is currently Full Professor and the director of the Pathology, Anatomy and Physiology Department at the School of Medicine of University of Navarra and researcher in the laboratory of Neurobiology of Alzheimer's disease of CIMA. Dra. Cuadrado-Tejedor combines her teaching (she teaches embryology and Anatomy at the School of Medicine and Neuroanatomy at the Master of Biomedicine) with her research work in the area of Neurosciences (AD). Her research has focused on the study of cellular and molecular bases of memory in animal models of AD with the aim of identifying new therapeutic targets and developing new pharmacological treatments that may delay or stop the progression of the disease. In relation to this, she has participated in different research projects focused on studying the molecular alterations associated with the processes of synaptic plasticity that occur after the administration of different treatments such as administration of histone deacetylase inhibitors (HDACs) and / or phosphodiesterase inhibitors (PDE). Ultimately, her research is mainly focused in the study of different factors that could provide cognitive resilience in AD.